Anthony Mire-Sluis

Latest from Anthony Mire-Sluis

Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and Analytics
CMC Forums
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and AnalyticsNext-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 2: Process Modeling and Analytics
byAnthony Mire-Sluis, Sarah Kennettand 8 more
Dec 17, 2020
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream Strategies
CMC Forums
Next-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream StrategiesNext-Generation Biotechnology Product Development, Manufacturing, and Control Strategies, Part 1: Upstream and Downstream Strategies
byAnthony Mire-Sluis, Sarah Kennettand 7 more
Oct 29, 2020

All from Anthony Mire-Sluis

Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes
CMC Forums
Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes
Development of Patient-Focused Commercial Specifications: Understanding Clinical Relevance and Criticality of Quality Attributes
Sep 22, 2020
+9
byAnthony Mire-Sluis, Jason Starkeyand 9 more
Special Report on Process- and Product-Related Impurities (A CMC Strategy Forum Special Focus Series): Extractables, Leachables, Particles, and
CMC Forums
Special Report on Process- and Product-Related Impurities (A CMC Strategy Forum Special Focus Series): Extractables, Leachables, Particles, and Aggregates
Special Report on Process- and Product-Related Impurities (A CMC Strategy Forum Special Focus Series): Extractables, Leachables, Particles, and Aggregates
Nov 17, 2016
+3
byAnthony Mire-Sluis, Stacey Maand 3 more
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
CMC Forums
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
Apr 12, 2016
+18
byCheryl Scott, Siddharth J. Advant, PhDand 18 more
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, The Roles of Bioactivity Assays in Lot Release and logo in a gray background | Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, The Roles of Bioactivity Assays in Lot Release and
Fill/Finish
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, The Roles of Bioactivity Assays in Lot Release and Stability Testing
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, The Roles of Bioactivity Assays in Lot Release and Stability Testing
Nov 17, 2015
+5
byNoel Rieder, Helene Gazzano-Santoroand 5 more
Effective Management of Contract Organizations: Keeping the Product Pipeline Moving, Compliant, and Available
Economics
Effective Management of Contract Organizations: Keeping the Product Pipeline Moving, Compliant, and Available
Effective Management of Contract Organizations: Keeping the Product Pipeline Moving, Compliant, and Available
Oct 15, 2015
+7
byAnthony Mire-Sluis, Julia Edwardsand 7 more
Analysis and Structure Characterization of Monoclonal Antibodies logo in a gray background | Analysis and Structure Characterization of Monoclonal Antibodies
Product Characterization
Analysis and Structure Characterization of Monoclonal Antibodies
Analysis and Structure Characterization of Monoclonal Antibodies
Sep 23, 2015
+4
byMark Schenerman, Brooks Sundayand 4 more
Lot Release and Characterization Testing of Live-Virus–Based Vaccines and Gene Therapy Products logo in a gray background | Lot Release and Characterization Testing of Live-Virus–Based Vaccines and Gene Therapy Products
Vaccines
Lot Release and Characterization Testing of Live-Virus–Based Vaccines and Gene Therapy Products
Lot Release and Characterization Testing of Live-Virus–Based Vaccines and Gene Therapy Products
Sep 23, 2015
+5
byJames Gombold, Keith Pedenand 5 more
Raw Material Control Strategies for Bioprocesses logo in a gray background | Raw Material Control Strategies for Bioprocesses
CMC Forums
Raw Material Control Strategies for Bioprocesses
Raw Material Control Strategies for Bioprocesses
Apr 14, 2015
+5
byGregory Beck, Mark Schenermanand 5 more
Drug Products for Biological Medicines: Novel Delivery Devices, Challenging Formulations, and Combination Products logo in a gray background | Drug Products for Biological Medicines: Novel Delivery Devices, Challenging Formulations, and Combination Products
CMC Forums
Drug Products for Biological Medicines: Novel Delivery Devices, Challenging Formulations, and Combination Products
Drug Products for Biological Medicines: Novel Delivery Devices, Challenging Formulations, and Combination Products
Apr 14, 2015
+3
byAnthony Mire-Sluis, Donna Frenchand 3 more
Accelerated Product Development: Leveraging Industry and Regulator Knowledge to Bring Products to Patients Quickly
Process Development
Accelerated Product Development: Leveraging Industry and Regulator Knowledge to Bring Products to Patients Quickly
Accelerated Product Development: Leveraging Industry and Regulator Knowledge to Bring Products to Patients Quickly
Dec 12, 2014
+9
byAnthony Mire-Sluis, Michelle Frazierand 9 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe